Caribou Biosciences, Inc.
CRBU
$1.86
$0.105.68%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.08% | -33.07% | -28.29% | -46.08% | -56.65% |
| Total Depreciation and Amortization | 19.06% | 20.80% | 20.19% | 11.40% | 5.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 108.35% | 140.59% | -22.50% | -3.82% | 140.76% |
| Change in Net Operating Assets | -257.95% | 46.33% | 0.76% | 30.12% | 133.78% |
| Cash from Operations | -1.23% | -10.71% | -34.29% | -48.14% | -28.01% |
| Capital Expenditure | 68.47% | 75.27% | 59.44% | 57.98% | 40.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 123.11% | 362.90% | 314.01% | 261.70% | 287.52% |
| Cash from Investing | 155.59% | 307.67% | 271.44% | 227.02% | 210.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -64.12% | -96.90% | -97.15% | -89.16% | -91.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -64.00% | -96.90% | -97.15% | -89.16% | -91.70% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 71.11% | 55.29% | -497.58% | -385.91% | -428.08% |